Effects of Cannabis on Prescription Drug Abuse Liability and Analgesia

PHASE1CompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

April 1, 2019

Primary Completion Date

December 6, 2022

Study Completion Date

December 6, 2022

Conditions
PainAbuse, Drug
Interventions
DRUG

Oxycodone

Oxycodone, 2.5 mg

DRUG

Cannabis (THC:CBD = ~ 1:0)

Cannabis with high THC concentration and negligible CBD concentrations

DRUG

Cannabis (THC:CBD = ~ 0:1)

Cannabis with high CBD concentration and negligible THC concentrations

DRUG

Cannabis (THC:CBD = ~ 1:1)

Cannabis with equivalent CBD and THC concentrations

DRUG

Placebo

Cannabis with negligible amounts of THC and CBD 0.0 mg oxycodone

Trial Locations (1)

10032

New York State Psychiatric Institute, New York

All Listed Sponsors
lead

New York State Psychiatric Institute

OTHER

NCT03679949 - Effects of Cannabis on Prescription Drug Abuse Liability and Analgesia | Biotech Hunter | Biotech Hunter